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The immunological response of Man to typhus fevers, caused by obligate intracel- 
lular  parasitic  bacteria  of  the  genus  Rickettsia,  includes  both  antibody  and  cell- 
mediated components  (CMI) 1 (1-3). The immune effector mechanisms that control 
intracellular rickettsial replication are unknown, but studies in animals indicate that 
they are mediated  through  immune T  lymphocytes  2 (4).  The relationship  between 
Rickettsia prowazekii-infected  cells to monocytes, macrophages, and lymphocytes in the 
classical typhus lesions (5) suggests the participation of CMI mechanisms other than 
phagocytosis  and  destruction  by activated  macrophages.  Thus,  the  basic  lesion,  a 
vasculitis  of small  blood  vessels,  consists  of focal  areas  of rickettsial  infection  of 
endothelial  cells accompanied by perivascular accumulations of monocytes, macro- 
phages, and lymphocytes. Some intravascular mononuclear cells, in contact with the 
luminal surface of endothelial  cells, presumably pass across the infected endothelial 
cells to perivascular sites, which might activate specific T  lymphocytes (6). Rickettsiae 
appear to be limited largely to the endothelial cells, despite their catholic in vitro host 
cell range (7). 
Macrophages have been the main focus in several studies as putative final effectors 
of the destruction of various rickettsial species by both antibody-mediated and CMI 
mechanisms  (2,  8-11).  Both  depend  upon  phagocytosis of extracellular  rickettsiae, 
which  is  artificially  facilitated  by  the  in  vitro  and  intraperitoneal  test  systems 
employed.  Peritoneal  macrophages  from  immune  animals  or  those  treated  with 
lymphokines from stimulated immune spleen ceils show increased capacity to destroy 
contained rickettsiae (8-11). However, in vivo studies raise questions of the relevance 
of these  macrophage-dependent  phenomena  to  control  of rickettsial  replication  in 
tissues during infections induced by more natural peripheral routes. Opportunity for 
macrophages to  interact  in  the  lesions with extracellular  rickettsiae  in  the classical 
* Supported by Contract No. DADA-I  7-71-1007 with the U.S. Army  Medical Research and Develop- 
ment Command, Office of the Surgeon General, Department of the Army. 
1  Abbreviations used in this paper: CM, control medium; CMI, cell-mediated immunity; CS, unstimulated 
leukocyte supernatant fluid; EDTA, ethylenediamine tetraacetate; ET, R. prowazekii; ET-S, supernatant 
fluid from ET antigen-stimulated typhus-immune leukocyte cultures; FCS, fetal calf serum; N, average 
number of rickettsiae per cell; Ni, average number of rickettsiae per infected cell; pl, percent cells infected; 
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role of phagocytic cells  may be limited  (12).  Indeed,  passively  transferred  immune 
serum, which facilitates rickettsial destruction by macrophages in vitro, fails to restrict 
rickettsial  replication  in  tissues  in  vivo  2  (4).  Although  Rickettsia  rnooseri (17. typhz) 
infection of mice activates  liver and spleen  macrophages  for enhanced  microbicidal 
action on Listeria monoqtogenes, neither activation of fixed macrophages for enhanced 
microbicidal  action with  BCG or Coomebacteriurn parvum, nor their ablation  by silica, 
influences  rickettsial  growth  in  the  spleen  of R.  rnooseri-infected  mice.  Nevertheless, 
adoptive transfer of immune T-lymphocytes markedly restricts rickettsial  replication 
in this site. 2 
This  initial  study  in  the  search  for  CMI  effector  mechanisms  in  typhus  fevers 
describes the production in cultures of  human blood leukocytes, upon immunologically 
specific  stimulation  with  R. prowazekii  antigen  or nonspecific  stimulation  with  the 
mitogen  phytohemagglutinin,  of a  soluble  host cell-specific factor(s)  that causes  the 
death  in culture of R. prowazekii  growing not only within  human  macrophages,  but 
also within  "somatic" target endothelial  cells and in fibroblasts  and that causes the 
specific lysis of R. prowazekiioinfected, but not uninfected fibroblasts. 
Materials and Methods 
Cell Culture Media.  Unless otherwise specified,  the basic medium  (CM)  was half-strength 
Dulbecco's medium with Earle's salts containing 0.1% glucose (I)/2 medium)  (Gibco Labora- 
tories,  Grand Island, NY) and  10% fetal calf serum (FCS)  (Gibco Laboratories).  RPMI  1640 
medium (Flow Laboratories, Inc., Rockville, MD) containing 10% heat-inactivated human AB 
serum  was  used  for the  production  of human  blood leukocyte supernatant  fluids.  Human 
umbilical cord endothelial cells were grown and tested either in M199 medium with Earle's 
salts  (Gibco Laboratories)  or in  RPMI  1640 medium,  each  supplemented  with  20%  heat- 
inactivated  human  AB serum  or FCS.  Human  blood monocyte-derived macrophages were 
allowed to develop, and were tested, in D/2 medium supplemented with 30% heat-inactivated 
human  AB  or  autologous  serum.  Except  for  the  initial  isolation  of endothelial  cells,  no 
antibiotics were added to any of the media. 
Cells. Three types of cells were routinely employed: (a) chicken embryo (CE) cells obtained 
from embryonated specific pathogen-free eggs (SPAFAS, Norwich, CT) as previously described 
(I 3);  (b) WI-38 diploid human fibroblastic cells; and (c) a continuous line of human embryonic 
skin and muscle fibroblasts (F-1000  line from Flow Laboratories). 
Endothelial  cells from human umbilical cord veins  (14) were plated  (0.5-1.0 ×  10  s viable 
cells  per cm  2)  in 35- or 60-ram plastic tissue  culture dishes  (Falcon Plastics,  Div. of Becton, 
Dickinson  &  Co.,  Cockeysville,  MD)  or  in  12-well  plastic  plates  (Linbro,  Div.  of Flow 
Laboratories, Hamden, CT),  incubated to confluence at  37°C, removed with trypsin-EDTA 
and either used directly or split  1:2 for further propagation. 
Macrophage cultures from human peripheral blood monocytes were prepared by modifica- 
tion of our basic method  (2). Briefly, mononuclear cells,  isolated  from venous blood by the 
Ficoll-Hypaque method (15) and suspended at a concentration of 1 X  106 mononuclear cells 
per ml in D/2 medium containing 30% heat-inactivated autologous or human AB serum, were 
dispensed in 0.6-ml volumes to each chamber of four-chamber culture slides  (Lab-Tek Div., 
Miles  Laboratories Inc., Naperville,  IL) and were incubated at  37°C for 6 d, with medium 
changes at 2 h and 3 d, to allow monocytes to develop into macrophages. 
General Cell Culture Methods. Cells  were trypsinized with 0.1% trypsin  (Gibco Laboratories) 
and 0.02% Na-EDTA (ethylene diaminotetra-acetic acid) in phosphate-buffered physiological 
saline (PBS), pH 7.2. Total and viable cell hemocytometer counts were made by trypan blue 
exclusion.  Cultures  were routinely incubated  in  humid  air containing 5% CO2  and,  unless 
otherwise specified,  at  32°C.  Irradiated  cells  received  3,000  rad  x-irradiation  as  previously 
described (13). 
Rickettsia. A plaque-purified line of Rickettsia  prowazekii (Breinl  strain)  (ET) of human origin 
with a history of 155 egg, 3 tissue culture, and 3 egg passages was propagated in the yolk sac of 1782  LEUKOCYTE  ANTIRICKETTSIAL  FACTORS 
embryonated specific pathogen-free chicken eggs (SPAFAS). Ordinary seeds were prepared as 
20% (wt/vol) infected yolk sac homogenates in 3.7% brain heart infusion broth (BBL Micro- 
biology Systems, Beeton, Dickinson & Co., Cockeysville,  MD). Highly purified seeds enriched 
in  viable rickettsiae were  prepared  from  the  light  bands from  Renografin gradients  (16). 
Convenient volumes were stored at -70°C. 
General Rickettsial  Methods.  R.  prowazekii  (Breinl)  antigen for  stimulating leukocytes  was 
prepared  from a  highly purified suspension (16) that  was  killed by 0.1% formalin at  4°C, 
washed by centrifugation, and resuspended in PBS, pH 7.0, to a concentration of 1 mg/ml (dry 
wt) determined optically. Rickettsial plaque counts were made in monolayers of primary CE 
cells in 60-mm plastic petri dishes (Falcon Plastics)  by modifications of the method of Wike et 
al.  (17). Cells were infected with rickettsiae either in suspension or in cultures of attached cells 
(13).  Rickettsial growth was measured by microscopic observation of slide chamber cultures 
(13). The Gimenez stain (18) was usually employed but, in some instances, methanol-fixed 
smears were stained by the Giemsa method or acetone-fixed smears were stained with fluores- 
cein-conjugated human typhus immune serum. 
Preparation of Stimulated Leukocyte Supernatant Fluids. Stimulated supernatant fluids were pro- 
duced from leukocytes (19) obtained from healthy adult donors who either (a) had no history 
and no serological evidence of previous typhus infection or vaccination, or (b) had recovered 
from an infection with R. prowazekii or, in some instances, R. mooserL Venous blood was drawn 
into containers containing 10 U  heparin (Upjohn Co., Kalamazoo, MI) per 1 ml blood; 1 ml 
6% dextran (Dextran T-250, Pharmacia, Uppsala, Sweden) in physiological saline was added 
for  each  10 ml of blood; and, after -40 min at  37°C, leukocyteswere harvested from the 
leukoplasma and washed three times in RPMI  1640 medium by centrifugation at 4°C. The 
cells were adjusted to the desired concentration in RPMI 1640 medium containing 10% heat- 
inactivated human AB serum or FCS. For the ~roduction of stimulated leukocyte supernatant 
fluids,  1 ml of suspension containing 1 X  10  leukocytes and  1 /~g  ET antigen or purified 
phytohemagglutinin (Wellcome Reagents, Ltd.,  Beckenham, England)  (PHA)  per milliliter 
was added to each of a  series of tissue culture tubes (No.  3033, Falcon Plastics)  or 20 ml of 
suspension containing 1 ×  10  s leukocytes and 3 #g ET antigen or PHA per ml was added to 
each 75-cm 2 plastic tissue culture flask (Costar, Data Packaging, Cambridge, MA). Incubation 
was at 37°C for  18-24 h. The centrifuged supernatant fluid was cultured, passed through a 
0.22-/zm Millipore filter (Millipore/Continental  Water Systems,  Bedford,  MA) and stored at 
-20°C or -70°C in small volumes. Control supernatant fluids were collected from similar, but 
unstimulated, cultures. 
Assay  Methods for  Antirickettsial  and  Cytolytic Actions of Leukocyte Supernatant Fluids.  Initial 
observations were made at intervals over 48 h incubation at 32°C by microscopic examination 
of slide chamber cultures to which ET-S or PHA-S diluted in CM was added after infection. 
Separate  assay  methods  subsequently were  developed  for  the  antirickettsial and  cytolytic 
actions. 
Intracellular  antirickettsial  action, devoid ofcytolytic action, was measured by a modification 
of the slide chamber method. The medium over confluent cultures of host cells (F-1000 human 
fibroblasts unless otherwise indicated) growing in plastic vessels was replaced with CM or CS 
or with ET-S or PHA-S diluted in CM. After an 18-h incubation  at 32°C, the cells were washed 
three times with CM, removed with trypsin-EDTA, centrifuged, resuspended in CM, infected 
in suspension, washed in CM, and distributed to four-chamber culture slides, 2.5 ×  10' cells per 
chamber in 0.5 ml CM. Slides were removed at intervals during a 40-48-h incubation period, 
heat  fixed,  and stained with Gimenez stain. The rickettsiae in 300 cells  per condition were 
counted; percent cells infected (pl), average number of rickettsiae per cell  (N),  and average 
number of rickettsiae per infected cell (-M) were calculated (13). 
The cytolytic action of stimulated supernatant fluids was measured by a modified microtiter 
method (20), which depends on the direct counting of crystal violet-stained residual cells in flat 
bottom 96 well microtiter plates (Linbro). A washed suspension of trypsinized infected F-1000 
cells (4 ×  10  a cells/ml CM) was distributed to the microtiter plates, 0.1 ml per well. After a 6- 
h incubation, the CM was replaced with 0.1 ml fresh CM, CS, ET-S, or PHA-S, usually diluted 
1:2 or 1:10 in CM. At intervals during the subsequent 40-48-h incubation, the culture fluid 
was removed from the wells and the cells were fixed for 10 min in methanol, stained for 5 rain WISSEMAN AND WADDELL  1783 
with crystal violet (0.05% in physiological  saline),  washed in tap water, and dried.  The cells 
remaining  attached  in  each  of six  wells  per  condition  were  counted  under  a  dissecting 
microscope. Uninfected  cell  controls  accompanied each  condition.  Rickettsial  growth  was 
monitored in parallel slide chamber cultures. 
The term "pretreatment" designates the treatment of host cells before infection, usually with 
a leukocyte supernatant fluid for 18-20  h, and "posttreatment" designates  treatment of host 
cells after infection,  usually starting at ~6 h and continuing throughout the experiment. 
Radioisotope Uptake Methods.  To verify the action of inhibitors of protein, RNA, and DNA 
synthesis, F-1000 cells cultured in 12-well plastic Linbro plates were pulsed at the desired  time 
for 4 h with CM containing [SH]leueine (Amersham Corp., Arlington Heights, IL) (20-50/~Ci/ 
ml), [SH]uridine  (Schwarz/Mann Div., Becton, Dickinson  & Co., Orangeburg, NY; 10-15 #Ci/ 
ml), or [~'H]thymidine  (Amersham Corp.;  10/~Ci/ml). After discarding the medium, the cells 
were washed three times with D/2 medium and lysed with 0.5 ml 2% sodium dodecyl sulfate. 
A 50-pl aliquot of each sample was dried on a small piece of Whatman No.  1 filter paper, 
extracted with triehloroacetic acid, rinsed in two changes of 95% ethanol, dried, and counted 
in OCS (Amersham Corp.) scintillation fluid. 
Special Reagents.  The sources of some special reagents were as follows: emetine HCI (Boeh- 
ringer Mannheim, Federal Republic of Germany); cycloheximide (Gibeo Laboratories); acti- 
nomycin D  (Calbioehem-Behring Corp., American Hoechst Corp., La Jolla, CA);  mitomycin 
C  (Sigma Chemical Co.,  St. Louis,  MO); and chloramphenicol (Sehering  Corp., Bloomfield, 
N  J). 
Results 
A  Host Cell-specific Complex Action of Antigen-stimulated  Human Immune Leukocyte Super- 
natant Fluids on Rickettsia-infected  Cells In Vitro.  The supernatant  fluids from typhus- 
immune human leukocytes that had been stimulated with killed R. prowazekii antigen 
(ET-S) induced, after a lag period of a few hours, a complex set of effects when added 
to R. prowazekii-infected human (WI-38), but not chicken embryo fibroblasts (Fig.  1): 
(a)  an  antirickettsial  action  on  intracellular  rickettsiae,  as  evidenced  by  declines  in 
percent cells infected  (Pi) and average number of rickettsiae per cell  (N), and  (b)  a 
cytolytic action on infected cultures, as indicated by a  progressive, visible cell loss.  In 
a  minority of infected and treated cells, however, rickettsial growth appeared to be 
relatively  uninhibited.  Fig.  1  is  representative  of the  results  obtained  in  many 
experiments with the same lot of ET-S, different lots from the same individual  and 
lots from different immune subjects. Identical results were obtained with supernatant 
fluids  from leukocytes from either nonimmune or typhus-immune donors  following 
stimulation  with PHA.  Supernatant  fluids from unstimulated  immune human leu- 
kocytes  (CS)  or  from  ET  antigen-stimulated  leukocytes  from  nonimmune  donors 
failed to show either antirickettsial or cytolytic actions. 
Dissociation of IntraceUular Antirickettsial  Action from Cytolytic Action. Results similar to 
those  described  above  theoretically  could  have  been  obtained  by  selective  loss  of 
infected  cells.  However, intracellular  antirickettsial  action  of ET-S or PHA-S  in  the 
absence of complicating cytolysis was demonstrable when uninfected F-1000 human 
fibroblast cultures were pretreated with ET-S or PHA-S before infection and subse- 
quently  incubated  in  CM  and was evidenced by a  progressive decline  in pi and N 
over a 48-h period without detectable damage or loss of host cells (Fig. 2). Nevertheless, 
rickettsiae continued to grow in a small minority of cells. In contrast, cytolytic action 
measured in microtiter plates caused a  progressive loss of posttreated cells over a 48- 
period (Fig. 3). 
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Fxo.  1.  Apparent antirickettsial and  cytolytic actions of supernatant fluid from ET-antigen 
stimulated typhus-immune human leukocytes (ET-S) on slide chamber cultures of R. prowazekii 
(Breinl)-infected irradiated  WI-38, but not CE cells. Percentages in parentheses in left panels refer to 
estimated cell loss. ET-S was added 6 h after infection and was continuously  present thereafter. 
lial Cells. As with human fibroblasts,  growth of R. prowazekii  (Breinl)  was markedly 
restricted in cuhured macrophages pretreated with ET-S (Fig.  4). Similarly, after the 
initial  loss of incompetent cells,  R. prowazekii  (Breinl)  multiplied  in untreated endo- 
thelial cells but declined progressively in endothelial cells pretreated with ET-S (Fig. 
5). 
Lack of Direct Action of Stimulated Leukocyte Supernatant Fluids on ExtraceUular Rickettsiae. 
No direct rickettsiacidal action of unstimulated or stimulated leukocyte supernatant 
fluids was observed in two kinds of experiments  (data not shown).  (a)  There was no 
loss  of recoverable PFU from a  dilute  yolk sac suspension  of R. prowazekii  (Breinl) 
incubated  with  ET-S  and  then  assayed  in  nonresponder  CE  cell  monolayers.  (b) 
Direct microscopic measurement failed to reveal any effect on either uptake or growth 
of highly purified R. prowazekii  (Breinl)  pretreated with ET-S during the early stages 
of the first infection cycle in responder F-1000 fibroblasts. 
Some Actions of Stimulated Leukocyte Supernatant Fluids on  Uninfected Host  Cells. F-1000 
human fibroblasts, either pretreated with ET-S before trypsinization from flasks or in 
suspensions  incubated  in  the  presence  of ET-S,  showed  an  enhanced  tendency to 
aggregate, suggesting induction of some change in host cell surface. In the microtiter 
cytolysis assay system, pretreatment  of uninfected F-1000 cells  with ET-S or PHA-S 
followed by subsequent incubation in CM often resulted in significant enhancement WISSEMAN  AND  WADDELL 
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Fxo.  2.  Antirickettsial action (slide chamber) without cytolytic action (microtiter) in unirradiated 
F-1000 human fibroblasts pretreated for  18 h  with ET-S and then infected R. prowazekii (Breinl). 
Postinfection incubation was in CM in the absence of ET-S. RLB, Cells with intracellutar Gimenez- 
positive rickettsia-like bodies. 
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of cell growth, whereas continuous incubation in the presence of either ET-S or PHA- 
S  resulted  in  reversible  cytostasis,  but  never  cytolysis  (data  not  shown).  On  two 
separate occasions in which great care was taken to assure maximal dispersion of host 
cells, no effect of pretreatment of F-1000 cells with leukocyte supernatants was seen 
on the rate of uptake of untreated R. prowazekii in the suspended cell system (data not 
shown). 
Fate  of rickettsiae in  ET-S  Pretreated F-IO00  Cells. The  loss  of Gimenez-stainable 
organisms  from  ET-S  pretreated  F-1000  cells  was  found  to  reflect  loss  of  both 
morphological and infectious units. 
Replicates of pretreated, infected F-1000 human fibroblast cultures showing char- 
acteristie loss of rickettsiae by Gimenez stain were stained with (a) Giemsa stain or (b) 
fluorescein-labeled typhus convalescent serum. Neither method revealed the presence 
of organisms in numbers or distribution  not detected by the Gimenez stain.  Hence, 
the  disappearance of visible organisms from Gimenez-stained cell cultures  was not 
likely an artifact of the Gimenez stain. 
In two additional experiments (Table I), replicate cultures of R. prowazekii-infected ! 786  LEUKOCYTE  ANTIRICKETTSIAL  FACTORS 
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Fie.  3.  Cytolytic (microtiter) and apparent antirickettsial (slide chamber) actions of ET-S added 
to  unirradiated  F-1000 human  fibroblasts 6 h  after  infection with  R. prowazekii (Breinl) and 
continuously present thereafter. Note that when ET-S was added after infection both cytolytic and 
antirickettsial actions were usually expressed after a lag period of several hours. 
F-1000 human fibroblast ceils pretreated with CM, CS, or ET-S, the last showing the 
characteristic  decline of rickettsiae  in Gimenez-stained  preparations,  were disrupted 
at  48  h  and  the viable rickettsial  content was determined  by plaque  count.  In one 
experiment, the plaque count from ET-S-treated cells was <10  -2 of that of untreated 
cells. In the other, in which plaque counts were made at 0 h as well as 48 h, untreated 
cells showed about a  40-fold increase in titer, whereas the ET-S-treated cells showed 
a 69% decline. Concurrent microscopic examination revealed that the majority of cells 
lost  microscopically  detectable  rickettsiae,  whereas  a  minority  permitted  relatively 
normal rickettsial growth. 
Some Factors Influencing Antirickettsial and Cytolytic Actions of ET-S.  The antirickettsial 
and cytolytic actions of ET-S on F-1000 cells infected with R. prowazekii  (Breinl)  at 
32°C  were  essentially  the  same  at  35°C,  the  optimal  growth  temperature  for R. 
prowazekii  (7; Wisseman, C. L. Jr., et al., unpublished  observations),  and at 37°C, a 
more physiologic temperature  for F-1000 cells and for the action of lymphotoxins (21) 
(data not shown). Uninfected F-1000 cells were not lysed at 37°C. 
Host cell  (F-1000)  protein  synthesis  from newly transcribed  messenger RNA was 
required  for  the  expression  of the  antirickettsial  action,  but  not  for  the  cytolytic WISSEMAN AND WADDELL  1787 
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FIo. 4.  Antirickettsial  action induced by pretreatment (18 h) of cultured human 6-d macrophages 
with ET-S and then infected with R. prowazekii  (Breinl). Note that antirickettsial action is reflected 
by reduction in both percent cells infected (pi) and average number of rickettsiae per cell (N). In 
contrast, R. prowazekii  grew as expected (2) in untreated macrophages. 
action,  of ET-S  (data  not  shown).  Thus,  inhibition  of host  cell  transcription  with 
mitomycin C  (50 #g/ml)  (22)  or actinomycin D  (1  #g/ml)  (22)  or translation  with 
cycloheximide (1 #g/ml) or emetine (1 #g/ml)  (23)  during pre-infection exposure of 
host ceils to ET-S prevented expression ofantirickettsial action. Appropriate inhibition 
patterns of host cell protein and nucleic acid synthesis were confirmed by measuring 
the  uptake  of [nH]leucine,  [3H]thymidine,  and  [aH]uridine.  None  of the  inhibitor 
treatments  interfered with  rickettsial  growth.  In contrast,  none of these  treatments 
interfered with the cytolytic action of ET-S on R. prowazekii-infeeted  F-1000 cells. 
Relationship  between Rickettsial  Protein Synthesis and Replication and Induction of Suscepti- 
bility  of Host Cells to Cytolytic Action. R. prowazekii protein synthesis or replication was 
not  required  for the  infection  to  induce  susceptibility  to  ET-S  cytolysis in  F-1000 
fibroblasts.  Microtiter  cytolysis assays were  performed with  and  without  chloram- 
phenieol  (I0  #g/ml).  Chloramphenicol  inhibits  R.  prowazekii  growth  in  culture  at 
about  1.0  #g/ml  (24).  It  inhibits  procaryotic protein  synthesis  at  the  translational 1788  LEUKOCYTE  ANTIRICKETTSIAL FACTORS 
67 
I00 
50 
0 
Hu Umbil. Endothelium 
R. prowazekii  (Breinl) 
e&  CM 
o  z~  ET-S 
ca. 40% 
cell  loss 
o~ 
I  i  L  i  i  I 
0  5O 
Incubation Time  (h) 
÷6 
"5 
*4 
*5 
! 
I  ÷2 
÷1  Z 
0  ,z.  _o 
-I 
2 
5 
-4 
FIo. 5.  Antirickettsial action induced by pretreatment (18 h) of cultured human umbilical cord 
endothelial cells with ET-S and then infected with R. prowazekii (Breinl). Note the initial loss or 
detachment of infected cells which produced an early distortion of the curves depicting pi and N in 
control (CM) cultures, with subsequent recovery. In contrast, in ET-S treated cultures, both pi and 
N showed the characteristic progressive decline. 
level with  little effect  on  eucaryotic protein synthesis except  in  mitochondria  (25). 
Both  rickettsiae and  host cells were separately pre-incubated with chloramphenicol 
and  maintained  continuously  in  its  presence  during  infection  and  eytolytic assay. 
Parallel slide chamber cultures confirmed that 71-80% of the cells were infected with 
an average of 3-4.6 rickettsiae per cell at the beginning of the tests, that no rickettsial 
replication occurred  during the 40-h  incubation period in the presence of chloram- 
phenicol, and  that  the expected rickettsial replication occurred  in  its absence.  The 
curves depicting the course of ET-S-induced cytolysis in the presence or absence of 
chloramphenicol were indistinguishable from one another (data not shown). 
Thermal and pH Stability  of Antirickettsial  and Cytolytic Factors. Both antirickettsial and 
cytolytic actions of ET-S and PHA-S measured in the F-1000 cell-R, prowazekii (Breinl) 
system were destroyed either by heating for  1 h  at 56°C  or by exposure to pH  2  for 
24 h  (data not shown). WISSEMAN AND  WADDELL  1789 
TAnLE  I 
Intracellular Antirickettsial Action of ET-S and PHA-S on R. prowazekii  (Breinl)  in Human F-I O00 
Fibroblastic Cells:  Comparison of Microscopic  Slide Chamber Methods with Recove~ of Plaque-forming 
Units from Parallel Cultures 
Slide chamber counts 
Treatment  Pi  N 
0  h  48 h  0 h  48 h  N~/No 
Viable rickettsia recovery 
PFU/flask (× 10  -~) 
0 h  48 h  N~/N0 
Experiment 1 * 
CM  53  52  1.6  25.7  16.1  --  1,120 
CS  56  51  1.5  24.5  16.3  --  1,180 
ET-S  42  3.7  0.89  0.21  0.24  --  17.4 
PHA-S  43  10.7  0.84  3.9  4.6  --  318 
Experiment 2* 
CM  64  64  2.2  41.8  19  4.4  145 
CS (ET-S)  51  45  1.6  22.7  14  4.1  110 
ET-S  49  3.3  1.6  0,48  0.31  4.1  0.8 
CS (PHA-S)  52  52  1.7  28,8  17  4.0  118 
PHA-S  62  26  2.2  12,2  5.6  4.4  26 
m 
33 
27 
0.2 
30 
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In Experiment  no.  1, the various supernatant fluids were prepared from aliquots of the leukocytes obtained 
from  a  single  large  bleeding  of  a  typhus-immune  subject.  In  Experiment  no.  2,  the  ET-S  and  its 
corresponding CS were obtained  from  the leukoeytes of a  typhus-immune  individual  whereas the PHA-S 
and its corresponding CS were obtained  from a subject not immune to typhus. 
Note that, by both microscopic and plaque count methods, supernatants  from unstimulated  leukocytes 
had  no  detectable  effect  on  rickettsial  growth,  whereas  supernatants  from  both  antigen-  and  mitogen- 
stimulated  leukocytes strongly inhibited or killed intracellular rickettsiae. 
Discussion 
Supernatant  fluids  from  cultures  of  peripheral  blood  leukocytes  from  typhus- 
immune human subjects, after immunologically specific stimulation with R. prowazekii 
antigen or nonspecific stimulation with the mitogen PHA, exhibit two distinct kinds 
of  action  on  R.  prowazekii-infected  human  but  not  chicken  embryo,  fibroblasts 
("somatic"  cells)  and on  human endothelial  cells  ("target"  cells)  as well  as  macro- 
phages ("professional phagocytes"):  (a) a microbicidal action on intracellular, but not 
extracellular rickettsiae and (b) lysis of infected, but not uninfected cells. 
The data presented do not reveal whether the two apparently distinct actions are 
induced by two different components in the leukocyte supernatant fluids or whether 
a  single  molecular  species  is responsible  for both. Both methods of stimulating  the 
leukocytes, i.e., antigen and mitogen, are known to induce the production of a variety 
of lymphokines,  including  immune  interferon  (IFN-y)  and  lymphotoxins  (21,  26). 
Both types of action were always present  in the supernatant  fluids regardless  of the 
method of stimulation and both were equally susceptible to inactivation by heating 
to 56°C for 1 h or exposure to pH 2. 
The antirickettsial action exhibited certain features in common with interferon action 
in viral  infections  (27):  (a)  no direct  action upon the microbial  agent;  (b)  host cell 
species specificity  (this study; and Wisseman, C. L., Jr., and A. Waddell, manuscript 
in preparation);  (c)  antimicrobial  action induced by pre-infection treatment  of host 
cell;  and  (d)  antimicrobial  action  dependent  upon host cell  protein  synthesis  from 
newly  transcribed  messenger  RNA  under  the  influence  of  the  factor.  Additional 
properties are consistent with those of immune interferon (IFN-y) : (a) type of stimulus 1790  LEUKOCYTE ANTIRICKETTSIAL FACTORS 
required for production in leukocyte cultures (antigen, mitogen); (b) rapid production 
of factor(s)  (1-3  d)  (data  not  shown);  (c)  sensitivity  to  heat  and  pH  2;  and  (d) 
reversible cytostatic action on uninfected fibroblasts (27). 
The cytolytic action of stimulated leukocyte culture supernatant fluids is specific 
for R. prowazekii-infected  cells, does not act on uninfected "bystander" cells, results in 
the complete lysis of infected cells (Wisseman, C. L., Jr., and A. Waddell, manuscript 
in  preparation)  and  does not  require host  cell protein synthesis.  The change  from 
resistance to susceptibility  to  lysis can  be  induced  in  a  cell by infection with  1-3 
rickettsiae,  even  if  rickettsial  replication  and  protein  synthesis  are  continuously 
inhibited with chloramphenicol. Although some properties are superficially similar to 
those  reported  for lymphotoxin  (21,  28),  i.e.,  independence  from host  cell protein 
synthesis  and  slow  action  over  24+  h,  the  cytolytic factor of ET-S  and  PHA-S 
exhibited several properties that are substantially different: (a) more rapid production 
in  stimulated  leukocyte cultures;  (b)  action  over a  greater  temperature  range;  (c) 
greater  sensitivity  to  heat  inactivation;  (d)  far  more  restricted  range  of host  cell 
species; and (e) action limited to infected cells. On the other hand, growing experience 
with  IFN-y suggests  that,  in  addition  to  its  reversible cytostatic effect on  normal 
fibroblasts,  it  may  interfere with  the  growth  of tumor  cells  and  cause  death  of 
transformed cells (27, 29, 30). Thus, it is conceivable that IFN-y could have a cytolytic 
action on host cells that have been altered in some way by the intraeellular rickettsial 
infection.  Indeed,  a  subsequent  report  (Wisseman,  C.  L.,  Jr.,  and  A.  Waddell, 
manuscript  in  preparation),  presents  definitive evidence to  indicate  that  IFN-y is 
responsible for both antirickettsial and cytolytic actions of ET-S. 
Lymphokines have been described that one way or another restrict the replication 
of, or cause the death of, R. tsutsugamushi and Coxiella burnetii (11,  31)  within macro- 
phages. However, there is a  great paucity of information on the capacity of soluble 
factors from specifically or nonspecifically stimulated lymphocytes to restrict replica- 
tion of nonviral agents in cells that are not "professional" phagocytes, i.e., "somatic" 
or parenchymal cells, such  as  the endothelial  target cells of typhus infection. The 
reports of Kazar et al. (32) on inhibition of Chlamydia trachomatis growth in L cells and 
of Chinchilla and Frenkel (33) on inhibition of toxoplasma and besnoitia in fibroblasts 
and  kidney  cells  suggest  that  such  phenomena  may  occur  with  other  types  of 
intracellular  parasites.  In  a  recent  abstract,  Turco  and  Winkler  (34)  reported  an 
inhibition  of R. prowazekii growth  in  macrophages and  fibroblasts by lymphokines 
that may be similar to the antirickettsial action described here. 
A hypothesis was presented in the Introduction that cell-mediated immune effector 
mechanisms other than that of the classical activated macrophage variety logically 
must operate to explain the control of R. prowazekii infection in its endothelial target 
cells in tissues. The present study supports this possibility by demonstrating that, in 
in vitro systems, an immunologically specific stimulus causes immune human periph- 
eral  blood  leukocytes  to  produce  a  soluble  factor(s)  that  can  inhibit  and  kill  R. 
prowazekii,  not  only within  the  cells  in  which  it  normally  grows  to  produce  the 
characteristic pathophysiology of typhus, i.e., endothelial cells, but also in fibroblasts 
and in macrophages, and can cause selective lysis of infected cells. The possibility that 
other types of effector mechanisms exist, such as other soluble factors as well as the 
direct interaction between various subpopulations of T  lymphocytes, natural  killer WISSEMAN AND WADDELL  1791 
cells,  and  activated  macrophages with  infected  endothelial  cells remains to  be ex- 
plored. 
Summary 
Unique features of the primary site of rickettsial replication  in typhus fevers, i.e., 
within  the  endothelial  cells  of small  blood  vessels in  tissues,  suggest  that  effector 
mechanisms, other than those dependent on phagocytosis by activated macrophages 
with enhanced microbicidal properties, most likely are necessary to explain the cell- 
mediated immune control of intracellular rickettsial replication in these sites. Theo- 
retically, such mechanisms might involve contact between infected endothelial  cells 
and  activated  T  lymphocyte  subpopulations  or  macrophages  or  immunologically 
induced  soluble factors or lymphokines. Support  for the existence of at least one of 
these alternative effector mechanisms is presented here for Rickettsia prowazekii.  Cul- 
tures of human blood leukocytes, upon immunologically specific stimulation with R. 
prowazekii antigen or nonspecific stimulation with the mitogen phytohemogglutinin, 
produce  soluble  factor(s)  in  the  supernatant  fluid  which,  in  culture,  have  (a)  an 
intracellular  antirickettsial  action  on  R.  prowazekii-infected  human  endothelial  cells, 
fibroblasts,  and  macrophages,  and  (b)  a  specific cytolytic  action  on  R.  prowazekii- 
infected, but not uninfected bystander, human fibroblasts. Neither action is demon- 
strable in R. prowazekii-infected chicken embryo fibroblasts. The factor(s) has no direct 
antimicrobial action on extracellular rickettsiae and is inactivated by heating at 56°C 
for 1 h  or by acid treatment at pH 2. Expression of the antirickettsial action requires 
new  host  cell  messenger transcription  and  protein  synthesis, whereas  the  cytolytic 
action does not. The circumstances of production and action and the properties of the 
factor(s) responsible for the intracellular antirickettsial, and perhaps also the cytolytic 
action are consistent with those of immune interferon (IFN-y). 
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